Stockscreener 앱 받기
1.56
3.11%
-0.05
시간 외 거래:
1.56
전일 마감가:
$1.61
열려 있는:
$1.66
하루 거래량:
101.73K
Relative Volume:
0.51
시가총액:
$82.02M
수익:
-
순이익/손실:
$-68.96M
주가수익비율:
-0.9571
EPS:
-1.63
순현금흐름:
$-56.62M
1주 성능:
-10.86%
1개월 성능:
-1.27%
6개월 성능:
-25.71%
1년 성능:
-37.60%
1일 변동 폭
$1.56
$1.66
1주일 범위
$1.56
$1.7465
52주 변동 폭
$1.40
$3.47
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6664
주소
ONE RESEARCH WAY, PRINCETON
PMVP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PMVP | 1.56 | 82.02M | 0 | -68.96M | -56.62M | -1.63 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-19 | 개시 | Oppenheimer | Perform |
| 2021-08-02 | 개시 | Guggenheim | Buy |
| 2021-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-10-20 | 개시 | BofA Securities | Buy |
| 2020-10-20 | 개시 | Cowen | Outperform |
| 2020-10-20 | 개시 | Evercore ISI | Outperform |
| 2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
Sionna Therapeutics Appoints Laurie Stelzer to its Board of Directors - citybiz
ArrowMark Colorado Holdings LLC Expands Stake in PMV Pharmaceuti - GuruFocus.com
BML Capital Management LLC Grows Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
Icahn Enterprises Releases Third Quarter 2024 Financial Results - Defense World
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Receives $5.80 Average Target Price from Brokerages - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Upgraded at Oppenheimer - MarketBeat
Oppenheimer raises PMVP rating to Outperform, sets stock target on Q3 results - Investing.com UK
PMV Pharmaceuticals Inc (PMVP) Quarterly 10-Q Report - Quartz
PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results - The Manila Times
Rezatapopt Monotherapy Remains Under Study Following Discontinuation of Combination Cohort in TP53+ Solid Tumors - OncLive
Dr Cristofanilli on Applications for Liquid Biopsy–Based MRD Testing in Breast Cancer - OncLive
US Penny Stocks To Consider In October 2024 - Simply Wall St
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire
New Global Hematology Journal Strives to Feature Innovative and Adaptable Research - OncLive
SG Americas Securities LLC Invests $554,000 in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World
Menin Inhibitors for AML: A Roundtable on the Latest Advances - OncLive
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
ELVN-001 Appears Safe and Effective in Relapsed/Refractory CML - OncLive
Envestnet Asset Management Inc. Sells 2,501 Shares of Juniper Networks, Inc. (NYSE:JNPR) - Defense World
Point72 Asia Singapore Pte. Ltd. Takes $101,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire
Pawan Singh sharing his grief with Mata Rani, asking questions from his mind, Pawan Singh sharing his grief with Mata Rani, asking questions from his mind - AnyTV News
Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader
Stock market news: PC Jeweller shares hit 5% upper circuit- Check Details - MSN
Vanguard Personalized Indexing Management LLC Increases Position in PDD Holdings Inc. (NASDAQ:PDD) - Defense World
2 ASX shares I can’t ignore: PME and SOL - Rask Media
40% women with PCOD may get diabetes: Experts - The Times of India
Parvin Dabas, Pro Panja League Co-Founder, In ICU After Road Accident - Pratidin Time
Agency News | ⚡Pro Panja League Co-Founder and Actor Parvin Dabas Admitted to ICU Following Car Accident - LatestLY
Should PME shares be on your watchlist? - Rask Media
Power Mech Shares Gain on Securing Orders Worth Rs 865 Crore - EquityPandit
Power Mech rises on Rs 865-cr order win from Vedanta's subsidiary - Business Standard
Bowers & Wilkins Launches Px7 S2e “Ruby Red” and Px8 “Dark Forest” - HYPEBEAST
Bowers & Wilkins adds two new colors to PX7 S2e & PX8 headphones - Gstyle magazine
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India
Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat
PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India
Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio
NCCN Adds Denileukin Diftitox to CTCL Clinical Practice Guidelines in Oncology - OncLive
Dr Koff on the Role of Covalent BTK Inhibitors and Pirtobrutinib in MCL - OncLive
Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex
Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World
Dr El-Jawahri on the Effects of Sexual Health Interventions in HSCT Recipients - OncLive
Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):